This article by Christoph Schnorr and Peter Wagner from Consulting discusses how biopharma can address the personalised medicines market in a more effective way. They discuss how greater collaboration can increase productivity; help to refine solutions and reduce costs. It was published in the October 2014 edition of European Biopharmaceutical Review. Click here to read the current edition.
Article October 02, 2014